Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study

被引：0
|
作者：
C. Senn
B. Günther
A. W. Popp
R. Perrelet
D. Hans
K. Lippuner
机构：
[1] Berne University Hospital and University of Berne,Department of Osteoporosis, Inselspital
[2] Lausanne University Hospital,Center of Bone Disease, Bone and Joint Department
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone mineral density; Open-label study; Osteoporosis; Parathyroid hormone; Teriparatide; Trabecular bone score; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1945 / 1951
页数：6
相关论文
共 50 条
  • [21] EFFECT OF TWO DIFFERENT THERAPEUTIC REGIMENS OF CLODRONATE ON BONE MINERAL DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A 2-YEAR RANDOMIZED TRIAL
    Giusti, A.
    Girasole, G.
    Garzia, V.
    Siccardi, V.
    Locaputo, A.
    Diana, P.
    Ponte, M.
    Bianchi, G.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S260 - S260
  • [22] Vitamin k2 effects on the risk of fractures and on lumbar bone mineral density in osteoporosis - A randomized prospective open-label 3-year study
    Shiraki, M
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S160 - S160
  • [23] Commentary on "Differential effects of strength versus power training on bone mineral density in postmenopausal women: a 2-year longitudinal study"
    Preisinger, Elisabeth
    BRITISH JOURNAL OF SPORTS MEDICINE, 2007, 41 (10)
  • [24] Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study
    Berberoglu, Zehra
    Yazici, Ayse C.
    Demirag, Nilgun G.
    CLINICAL ENDOCRINOLOGY, 2010, 73 (03) : 305 - 312
  • [25] Effects of monthly intravenous ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment: The MONUMENT study
    Chiba, Ko
    Yamada, Shuta
    Yoda, Itaru
    Era, Makoto
    Yokota, Kazuaki
    Okazaki, Narihiro
    Ota, Shingo
    Isobe, Yusaku
    Miyazaki, Satsuki
    Tashiro, Shigeki
    Nakashima, Sawako
    Morimoto, Shimpei
    Sato, Shuntaro
    Tsukazaki, Tomoo
    Watanabe, Tsuyoshi
    Enomoto, Hiroshi
    Yabe, Yoshihiro
    Yonekura, Akihiko
    Tomita, Masato
    Ito, Masako
    Osaki, Makoto
    BONE, 2021, 144
  • [26] Alendronate (ALN) exposure-response modeling of bone turnover biomarkers and lumbar spine bone mineral density (BMD) in postmenopausal women with osteoporosis.
    Liu, Q.
    Jin, B.
    Wang, X.
    Stoch, A.
    Verbruggen, N.
    He, W.
    Ince, A.
    Czachur, M.
    McCaffrey, L.
    Miller, D.
    Panebianco, D.
    Denker, A.
    Woolf, E.
    Santora, A.
    Stone, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S70 - S70
  • [27] Superior Gains in Bone Mineral Density and Estimated Strength at the Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of a Phase 3, Open-Label Clinical Trial
    Langdahl, B.
    Libanati, C.
    Crittenden, D. B.
    Bolognese, M. A.
    Brown, J. P.
    Daizadeh, N. S.
    Engelke, K.
    Genant, H. K.
    Goemaere, S.
    Hyldstrup, Lars
    Jodar-Gimeno, E.
    Keaveny, T. M.
    Kendler, D.
    Lakatos, P.
    Maddox, J.
    Malouf, J.
    Massari, F. E.
    Molina, J. F.
    Ulla, M. R.
    Grauer, A.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] LONG-TERM EFFECT OF DENOSUMAB ON BONE MICROARCHITECTURE AS ASSESSED BY TISSUE THICKNESS-ADJUSTED TRABECULAR BONE SCORE (TBS) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM AND OPEN-LABEL EXTENSION (OLE)
    Hans, D.
    Mcdermott, M.
    Huang, S.
    Kim, M.
    Shevroja, E.
    Mcclung, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S157 - S158
  • [29] THE 3-YEAR EFFICACY OF ZOLEDRONIC ACID ON BONE MINERAL DENSITY OF LUMBAR SPINE AND NECK IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Mole, E.
    Zoupidou, K.
    Alexoudis, A.
    Moshou, D.
    Prelorentzos, G.
    Gazi, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S64 - S64
  • [30] Significant gains in bone mineral density following 1 and 2 years of IV ibandronate therapy in women with postmenopausal osteoporosis (PMO)
    Kagan, Risa
    Lane, Nancy
    Simonelli, Christine
    Barr, Charles
    Genant, Harold
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 1002 - 1002
12345